The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis

The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis

Abstract Background Retinopathy of prematurity (ROP) is typically treated with laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF). To the best of our knowledge, most systematic reviews have focused on comparing anti-VEGF against laser treatment while compa...

Full description

Bibliographic Details
Main Authors: Jing Chen, Qingfei Hao, Jing Zhang, Yanna Du, Haoming Chen, Xiuyong Cheng
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Italian Journal of Pediatrics
Subjects:
Aflibercept
Bevacizumab
Conbercept
Laser
Retinopathy of prematurity
Ranibizumab
Online Access:https://doi.org/10.1186/s13052-023-01543-3

Similar Items

Similar Items